Valuates Reports India United Kingdom United States of America

07.08.2025 - 18:09:05

Cancer Biomarkers Market Size to Grow USD 42170 Million by 2030 at a CAGR of 11.4% | Valuates Reports

size accounted for USD 1,204.2 Million in 2020, and is estimated to reach USD 6,804.9 Million by 2028, registering a CAGR of 20.9% from 2021 to 2028.

- Cancer Gene Therapy Market was valued at USD 1,389.42 Million in 2020 and is estimated to reach USD 11,359.35 Million by 2030, registering a CAGR of 23.3% from 2021 to 2030.

- The global cancer diagnostics market size was valued at USD 168,600.04 Million in 2020, and is projected to reach USD 280,590.21 Million by 2028, registering a CAGR of 6.9% from 2021 to 2028.

- Pancreatic Cancer Market

- Bile Duct Cancer -Epidemiology Forecast to 2028

- Boron Neutron Capture Therapy (BNCT) Market was estimated to be worth USD 96.6 Million in 2023 and is forecast to a readjusted size of USD 2090.2 Million by 2030 with a CAGR of 51.3% during the forecast period 2024-2030.

- Small Cell Lung Cancer Market

- Oncology and Cancer Treatment Drug Market

- In-Vitro Cancer Diagnostics Market

- The Live Cell Imaging Market is anticipated to grow at the rate of 8.9% CAGR by 2027.

- Virtual Oncology market is projected to reach USD 7139.8 Million in 2029, increasing from USD 2917 Million in 2022, with a CAGR of 12.8% during the period of 2023 to 2029.

- Cancer Vaccine Market

- Prostate Cancer Diagnostics Market was estimated to be worth USD 13430 Million in 2023 and is forecast to a readjusted size of USD 22860 Million by 2030 with a CAGR of 7.8% during the forecast period 2024-2030.

- Prostate Cancer Biomarker Market

- In-Vitro Colorectal Cancer Screening Tests Market was estimated to be worth USD 1044.9 Million in 2023 and is forecast to a readjusted size of USD 1526.7 Million by 2030 with a CAGR of 5.5% during the forecast period 2024-2030.

- Precision Cancer Medicine market is projected to reach USD 350430 Million in 2029, increasing from USD 161690 Million in 2022, with a CAGR of 12.5% during the period of 2023 to 2029.

- Cancer Early Detection market is projected to reach USD 367.8 Million in 2029, increasing from USD 215 Million in 2022, with a CAGR of 7.3% during the period of 2023 to 2029.

DISCOVER OUR VISION: VISIT ABOUT US!

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.

To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.

YOUR FEEDBACK MATTERS: REACH OUT TO US!

Valuates Reports
sales@valuates.com
For U.S. Toll-Free Call 1-(315)-215-3225
WhatsApp: +91-9945648335
Website: https://reports.valuates.com
Blog: https://valuatestrends.blogspot.com/
Pinterest: https://in.pinterest.com/valuatesreports/
Twitter: https://twitter.com/valuatesreports
Facebook: https://www.facebook.com/valuatesreports/
https://www.facebook.com/valuateskorean
https://www.facebook.com/valuatesspanish
https://www.facebook.com/valuatesjapanese
https://valuatesreportspanish.blogspot.com/
https://valuateskorean.blogspot.com/
https://valuatesgerman.blogspot.com/
https://valuatesreportjapanese.blogspot.com/